Sexual Health
Personal care, grounded in evidence.
Two reproductive and sexual-signaling peptides with very different evidence and regulatory status.
Bremelanotide (PT-141)
An FDA-approved medicine exists for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women. Other uses or preparations are not FDA-approved.
Kisspeptin
A reproductive-signaling peptide studied for its role in the hypothalamic-pituitary-gonadal axis. Compounded products are not FDA-approved, and available safety data are limited.
View available options
Educational information only. A licensed clinician should assess symptoms, appropriateness, and risks.